SIMLIBIS Trademark

Trademark Overview

On Friday, October 18, 2013, a trademark application was filed for SIMLIBIS with the United States Patent and Trademark Office. The USPTO has given the SIMLIBIS trademark a serial number of 86096008. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, May 28, 2024. This trademark is owned by Gilead Sciences Limited. The SIMLIBIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, antivirals; anti-inflammatories; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention and treatment of hepatitis and HIV/AIDS; anti-infectives
simlibis

General Information

Serial Number86096008
Word MarkSIMLIBIS
Filing DateFriday, October 18, 2013
Status710 - CANCELLED - SECTION 8
Status DateTuesday, May 28, 2024
Registration Number5332301
Registration DateTuesday, November 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2014

Trademark Statements

Goods and ServicesPharmaceuticals, namely, antivirals; anti-inflammatories; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention and treatment of hepatitis and HIV/AIDS; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGILEAD SCIENCES IRELAND UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill Co. Cork,
IE
Party NameGILEAD SCIENCES IRELAND UC
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE
Party NameGilead Sciences Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, October 22, 2013NEW APPLICATION ENTERED
Friday, October 25, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 3, 2014ASSIGNED TO EXAMINER
Monday, February 3, 2014LETTER OF SUSPENSION E-MAILED
Monday, February 3, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, February 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 3, 2014SUSPENSION LETTER WRITTEN
Monday, February 3, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 29, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 3, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 31, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 14, 2014ASSIGNED TO LIE
Friday, April 25, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 25, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 14, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 3, 2014PUBLISHED FOR OPPOSITION
Tuesday, July 14, 2015SOU EXTENSION 2 GRANTED
Tuesday, July 29, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 12, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 27, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, January 27, 2015SOU EXTENSION 1 FILED
Monday, March 16, 2015SOU EXTENSION 1 GRANTED
Thursday, March 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 6, 2015SOU TEAS EXTENSION RECEIVED
Monday, July 6, 2015SOU EXTENSION 2 FILED
Tuesday, December 1, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, December 1, 2015SOU EXTENSION 3 FILED
Tuesday, December 1, 2015SOU EXTENSION 3 GRANTED
Friday, April 29, 2016SOU EXTENSION 4 FILED
Friday, April 29, 2016SOU EXTENSION 4 GRANTED
Tuesday, November 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, July 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 29, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 29, 2016SOU EXTENSION 5 FILED
Thursday, December 1, 2016SOU EXTENSION 5 GRANTED
Friday, December 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, May 24, 2017NOTICE OF ALLOWANCE CANCELLED
Thursday, October 12, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 28, 2024CANCELLED SEC. 8 (6-YR)
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

simlibis treatment preparations pharmaceutical diseases disorders anti liver prevention infectives hepatitis